PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
4.360
-0.680 (-13.49%)
At close: Nov 13, 2026, 4:00 PM EST
4.420
+0.060 (1.38%)
After-hours: Nov 13, 2026, 7:59 PM EST
PepGen Market Cap
PepGen has a market cap or net worth of $301.97 million as of November 13, 2026. It is the 17,898th most valuable company in the world and the 3,161st biggest in the United States. Its market cap has decreased by 14.38% in one year.
Market Cap
301.97M
Enterprise Value
212.77M
1-Year Change
-14.38%
Global Rank
Country Rank
#3,161 United States
Category
ChartMarket Cap Chart
Since May 6, 2022, PepGen's market cap has increased from $288.65M to $301.97M, an increase of 4.62%. That is a compound annual growth rate of 1.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 301.97M | -32.53% |
| Dec 31, 2025 | 447.55M | 262.28% |
| Dec 31, 2024 | 123.54M | -23.71% |
| Dec 29, 2023 | 161.93M | -48.75% |
| Dec 30, 2022 | 315.96M | 9.46% |
| May 6, 2022 | 288.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 315.40M |
| Altimmune | 312.32M |
| Enanta Pharmaceuticals | 311.35M |
| ProKidney | 309.94M |
| Eikon Therapeutics | 308.74M |
| Benitec Biopharma | 308.71M |
| Kyverna Therapeutics | 306.63M |
| X4 Pharmaceuticals | 305.83M |